• Grx2, HNRNPA2B1, and Diabetic Cataract Ferroptosis

  2026-08-17

  The reference study identifies a redox-regulated mechanism linking high-glucose stress to ferroptosis in lens epithelial cells: glutaredoxin 2 protects cells by limiting HNRNPA2B1 S-glutathionylation and its downstream effects on PTEN/AKT signaling. Its integrated use of LC-MS/MS, co-immunoprecipitation, lentiviral manipulation, and ferroptosis-related readouts provides a useful framework for studying diabetes-mediated cataractogenesis.

• VE-822 ATR Inhibitor for DDR Assay Design

  2026-08-17

  VE-822 provides a practical way to interrogate ATR-dependent replication-stress responses and build sensitization assays with radiation or gemcitabine. This workflow-focused guide connects PDAC chemoradiotherapy experiments with emerging nuclear cGAS and LINE-1 genome-stability biology while clearly separating established evidence from testable hypotheses.

• TMRE mitochondrial membrane potential assay kit: Guide

  2026-08-16

  Turn ΔΨm changes into a practical readout for apoptosis, sodium-overload models, and mitochondrial physiology. This workflow combines TMRE staining, CCCP validation, high-throughput planning, and troubleshooting for more interpretable mitochondrial depolarization measurement.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-15

  Track mRNA uptake and functional EGFP expression in the same experiment with a dual-fluorescence reporter built for delivery-system optimization. The workflow links particle entry, intracellular trafficking, translation, and immune-response troubleshooting for nanoparticle, macrophage, and transdermal cancer research.

• (S)-Mephenytoin in CYP2C19 Assays

  2026-08-14

  (S)-Mephenytoin is a practical CYP2C19 substrate for separating intrinsic enzyme activity from transport, uptake, and tissue-level effects. This guide translates its biochemical benchmark into workflows for recombinant enzymes, microsomes, and hiPSC-derived intestinal organoid monolayers, with troubleshooting steps for solvent control, matrix interference, and low metabolite recovery.

• p-Cresyl Sulfate and Aortic Valve Calcification

  2026-08-14

  The reference study identifies p-cresyl sulfate as a direct enhancer of calcification in aortic valvular interstitial cells and connects this effect to HIF-1α activation, klotho loss, and impaired SIRT1-linked regulation of NF-κB and RUNX2. Its porcine-cell and rat CKD experiments provide a mechanistic framework for studying how protein-bound uremic toxins may contribute to calcific aortic valve disease and suggest klotho or SIRT1 modulation as testable intervention strategies.

• Tofacitinib (CP-690550): Mechanism & Benchmarks

  2026-08-13

  Tofacitinib (CP-690550) is an oral Janus kinase inhibitor used to study JAK/STAT-dependent immune signaling. Its benchmark activities include inhibition of interleukin-driven lymphocyte proliferation and modulation of GM-CSF-reprogrammed rheumatoid arthritis macrophages.

• Selective Autophagy Tunes IRF3 Stability

  2026-08-13

  The reference study shows that CALCOCO2/NDP52-mediated selective autophagy degrades IRF3 in a virus load-dependent manner, while PSMD14 preserves basal IRF3 by removing K27-linked ubiquitin chains at lysine 313. These findings define a post-translational checkpoint that balances type I interferon production with immune suppression and clarify how autophagy intersects with antiviral transcription factor regulation.

• Oseltamivir acid: Assay Design for Influenza Research

  2026-08-12

  Oseltamivir acid is an influenza neuraminidase inhibitor with a distinct active-metabolite profile. This guide connects neuraminidase, cell-based, resistance, and translational assay decisions while showing how humanized-mouse prodrug research can inform—without overextending—influenza antiviral research.

• Tetrahydromagnolol for CB2 Signaling Studies

  2026-08-12

  Tetrahydromagnolol is a potent peripheral CB2 receptor agonist for separating receptor-proximal cannabinoid signaling from downstream inflammatory, analgesic, and cell-motility phenotypes. This workflow-oriented guide shows how to optimize dosing, distinguish CB2 activity from GPR55 antagonism, and cautiously extend the platform into TNBC metastasis assays.

• Quaternization Reprograms Lung-Targeted mRNA Delivery

  2026-08-11

  The 2024 Theranostics study shows that N-quaternization of a lipid-like carrier can convert systemic mRNA distribution from spleen preference to highly selective lung delivery. The work provides a ligand-free strategy for improving non-liver mRNA delivery, while also identifying important limits for translating organ-level targeting into therapeutic performance.

• ApexPrep DNA Plasmid Miniprep Kit for AML Research

  2026-08-11

  Build reproducible plasmid workflows for cloning, sequencing, and mechanistic AML experiments with the ApexPrep DNA Plasmid Miniprep Kit. Its alkaline-lysis membrane format supports high- and low-copy vectors while creating a practical path from LMO2/LDB1 construct preparation to downstream validation and transfection.

• Protein A/G Magnetic Beads: Practical Workflow

  2026-08-10

  Protein A/G Magnetic Beads support Fc-mediated antibody capture for antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation from complex samples. They should be treated as research-use affinity reagents requiring antibody, buffer, and sample-specific optimization, not as diagnostic or medical products or as a substitute for assay controls.

• Z-VAD-FMK: Reading Cell Death Correctly

  2026-08-09

  Z-VAD-FMK is more than a pan-caspase inhibitor: it is a causal probe for distinguishing apoptosis from membrane-driven and alternative cell-death programs. This article uses ExoU-induced host-cell injury to develop a more rigorous framework for apoptosis inhibition, caspase activity measurement, and assay interpretation.

• PF-04971729 Workflow for SGLT2 Research

  2026-08-08

  Build cleaner glucose-transport, metabolic, cardiovascular, and intestinal-barrier experiments with the highly selective SGLT2 inhibitor Ertugliflozin. This practical guide connects assay design, dosing logic, translational endpoints, and troubleshooting for reproducible diabetes mellitus research.

557 records 8/38 page Previous Next First page 上5页 678910 下5页 Last page